Incyte shares slip after BMO analysts cut rating of drugmaker By Investing.com Incyte shares slip after BMO analysts cut rating of drugmaker…
Incyte-Aktie legt um 1,33 Prozent zu (59,6756 €) An der US-amerikanischen Börse liegt der Anteilsschein von Incyte gegenwärtig im Plus. Zuletzt zahlten Investoren für das Wertpapier 64,06 US-Dollar.…
Incyte, Squarespace rise; Chimera Investment, Amazon fall, Monday, 5/13/2024 Stocks that are trading heavily or have substantial price changes on Monday: Incyte, Squarespace rise; Chimera Investment, Amazon fall…
Incyte shares dip after earnings, guidance miss By Investing.com Incyte shares dip after earnings, guidance miss…
Incyte earnings missed by $0.18, revenue fell short of estimates By Investing.com Incyte earnings missed by $0.18, revenue fell short of estimates…
Incytes (INCY) Q1 Earnings & Revenues Fall Shy of Estimates Incytes (INCY) first-quarter 2024 earnings and revenues miss estimates. The company maintains 2024 revenue guidance for its lead drug, Jakafi.…